findmyKOL
Clinical trialNCT02764593CompletedPhase 1Interventional

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

SponsorRTOG Foundation, Inc.Enrollment40Head and Neck Squamous Cell Carcinoma (HNSCC)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the safety of adding nivolumab to several chemotherapy platforms with weekly cisplatin, high-dose cisplatin, cetuximab or radiation therapy alone.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford Cancer Institute

    Palo Alto, California, United States

  • University of Florida Cancer Center at Orlando Health

    Orlando, Florida, United States

  • Emory University/winship Cancer Institute

    Atlanta, Georgia, United States

  • University of Louisville

    Louisville, Kentucky, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Providence Portland Medical Center

    Portland, Oregon, United States

  • Upmc - Shadyside Hospital

    Pittsburgh, Pennsylvania, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Inova Fairfax Hospital

    Falls Church, Virginia, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CetuximabCisplatinNivolumab
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
25 Sept 2018
Completion
21 Feb 2022
Last update posted
29 Nov 2022
Registered enrollment
40
Registry id
NCT02764593
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.